Lens culinaris-agglutinin-reactive fraction of alpha-fetoprotein is a prognostic biomarker in atezolizumab plus bevacizumab for hepatocellular carcinoma

AFP-L3 is a useful biomarker for predicting the response and prognosis of patients with ATZ/BV for u-HCC. AFP-L3 should be measured together with AFP and DCP levels.

Authors

Institutions

Publication Details

Journal
European Journal of Gastroenterology & Hepatology
Published
2025-04-01
DOI
https://doi.org/10.1097/meg.0000000000002979
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lens culinaris-agglutinin-reactive fraction of alpha-fetoprotein is a prognostic biomarker in atezolizumab plus bevacizumab for hepatocellular carcinoma

Jumpei Okamura, Hideyuki Tamai
European Journal of Gastroenterology & Hepatology
Hepatocellular Carcinoma Treatment and Prognosis
article

Lens culinaris-agglutinin-reactive fraction of alpha-fetoprotein is a prognostic biomarker in atezolizumab plus bevacizumab for hepatocellular carcinoma

Jumpei Okamura, Hideyuki Tamai
article en

Abstract

AFP-L3 is a useful biomarker for predicting the response and prognosis of patients with ATZ/BV for u-HCC. AFP-L3 should be measured together with AFP and DCP levels.

European Journal of Gastroenterology & HepatologyVol. 37(9)
Wakayama Rosai Hospital (JP)
Good health and well-being
Openalex Percentile: Top 84%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lens culinaris-agglutinin-reactive fraction of alpha-fetoprotein is a prognostic biomarker in atezolizumab plus bevacizumab for hepatocellular carcinoma — Jumpei Okamura, Hideyuki Tamai · European Journal of Gastroenterology & Hepatology (2025) | TGRS Research Map | TGRS